AHCO Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
745.6M
+0.7%
740.3M
-9.7%
819.8M
-3.1%
846.3M
+25.9%
672.4M
Cost of Revenue
630.8M
-0.8%
636.1M
-10.2%
708.3M
+5.1%
674.1M
+26.3%
533.8M
Gross Profit
114.8M
+10.2%
104.2M
-6.5%
111.5M
-35.2%
172.2M
+24.3%
138.5M
Operating Expenses
282.7M
+13.9%
248.3M
+134.2%
106.0M
-56.9%
245.8M
+158.4%
95.1M
R&D
0
0
0
0
0
SG&A
88.7M
-7.7%
96.1M
+0.2%
95.9M
-11.1%
107.9M
+22.4%
88.1M
Operating Income
-167921000
-16.6%
-144071000
-2724.7%
5.5M
+107.5%
-73656000
-269.8%
43.4M
EBITDA
133.7M
+11.0%
120.5M
+7.6%
112.0M
-26.3%
151.8M
+7.6%
141.1M
Net Income
-152766000
-15.1%
-132719000
-792.3%
-14873000
+85.4%
-101537000
-494.3%
25.8M
EPS (Basic)
$-1.13
-14.1%
$-0.99
-725.0%
$-0.12
+84.2%
$-0.76
-547.1%
$0.17
EPS (Diluted)
$-1.13
-14.1%
$-0.99
-725.0%
$-0.12
+84.6%
$-0.78
-558.8%
$0.17
Shares (Diluted)
136.4M
+0.2%
136.1M
+0.3%
135.8M
+3.3%
131.5M
-4.2%
137.2M
AdaptHealth (AHCO) — Financials